Skip to content
healthcare.dev

Alocane Max

NDC 68229-408, Lidocaine Hydrochloride and Benzalkonium Chloride, spray, from Quest Products LLC.

Product NDC
68229-408
Status
Listed
Labeler
Quest Products LLC
Dosage form
SPRAY
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M017
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68229-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE4 g/100mL
  • BENZALKONIUM CHLORIDE.13 g/100mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
68229-408-0168229040801104 mL in 1 BOTTLE, SPRAY (68229-408-01)
68229-408-0268229040802118 mL in 1 BOTTLE, SPRAY (68229-408-02)
68229-408-0368229040803124 mL in 1 BOTTLE, SPRAY (68229-408-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68229-408 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68229-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68229-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.